Assessment of Global Disease Activity in Rheumatoid Arthritis by Patients and Physicians: Differences Across Countries in the METEOR Database.

Authors: Gvozdenović E1, Wolterbeek R, Allaart CF, Brenol C, Dougados M, Emery P, Ferraccioli G, van der Heijde D, Huizinga TW, Kay J, Martin Mola E, Moots RJ, da Silva JA, Smolen J, Veale D, Landewé RB.

Source: J Clin Rheumatol. 2015 Oct;21(7):349-54. doi: 10.1097/RHU.0000000000000296.

The aim of the study was to compare the differences between patient global disease activity (PtGDA) and physician global disease activity (PhGDA) score within and across 13 countries in the METEOR (Measurement of Efficacy of Treatment in the “Era of Outcome” in Rheumatology) database.

Differences between patients’ and physicians’ assessment of GDA vary across the countries. Influence of country must be taken into account when interpreting discordances between the patient’s and the physician’s assessment of GDA in rheumatoid arthritis.

Select your region and press submit to request this article from your local library
Share this article
Share on FacebookTweet about this on TwitterShare on Google+Share on LinkedIn